Craniopharyngioma is a rare clinical entity that poses a significant management challenge given their location and propensity to recur. As part of a minimally disruptive treatment paradigm, the expanded endonasal approach has the potential to improve rates of resection, improve postoperative visual recovery, and minimize surgical morbidity. This article updates the otolaryngologic community on the basic principles and techniques regarding the incorporation of the endoscopic, endonasal approach in the management paradigm of craniopharyngioma.
Key points
- •
Gross total resection of craniopharyngioma reduces the likelihood of recurrence.
- •
Planned subtotal resection +/− adjuvant radiation therapy may be a reasonable treatment approach in selected cases.
- •
The transsphenoidal corridor and endoscopic, endonasal technique are used to resect not only sellar and sellar-suprasellar but also purely suprasellar intraventricular craniopharyngioma.
- •
A key aspect of this technique is the expansion of the operative field by incorporation of the transtuberculum and transplanum approaches.
- •
The primary limitation of the transsphenoidal approach is its lateral reach, and as a general rule, this approach should not be applied to tumors extending more than a centimeter beyond the lateral limits of the exposure.
Introduction
Craniopharynigoma are rare, benign tumors of the central nervous system. Thought to arise from remnants of Rathke pouch in the sellar region, they represent less than 1% of all primary central nervous system tumors. Despite their benign histology, these tumors have posed a significant treatment challenge. Their central location in the sellar and suprasellar region and frequent invasion into critical neurovascular structures, such as the pituitary gland, hypothalamus, and optic apparatus, makes gross total resection (GTR) challenging. Although tumors may still recur after GTR the likelihood increases dramatically with subtotal resection. Nevertheless, significant controversy exists regarding the optimal treatment strategy, with some groups pursuing conservative subtotal resection with either upfront or salvage radiotherapy or radiosurgery to lessen the risks of aggressive surgical resection.
As these treatment paradigms have evolved, so too have the surgical techniques and approaches to craniopharyngioma, with the goal of maximizing resection and minimizing collateral damage. Traditional transcranial approaches require some degree of brain retraction and manipulation of cerebrovascular structures that lay between the surgeon and the pathology. The transsphenoidal approach offers a more direct route to the sellar/suprasellar region and if performed with the operating microscope provides only a limited field of view, which often precludes safe and complete resection of these lesions. The use of the transsphenoidal corridor was broadened with the development of expanded approaches, which offered a safe alternative method for reaching suprasellar craniopharyngioma. The incorporation of the endoscope was the next step on the evolutionary ladder. By virtue of an improved field of view and superb illumination, this allowed for further expansion of the endonasal corridor. Finally, the development of a variety of complementary multilayer techniques to repair the skull base minimized the risk of postoperative cerebrospinal fluid (CSF) leak. Several groups have now published their series incorporating these innovations into a fully endoscopic, endonasal, extended transsphenoidal approach for sellar and suprasellar craniopharyngioma.
Epidemiology and Clinical Characteristics
Craniopharyngioma is a histologically benign, but locally aggressive sellar/suprasellar tumor characterized by a propensity to involve surrounding neurovascular structures. The overall incidence rate is between 1.3 and 1.7 cases per 1,000,000 person-years. As is often noted in the literature, there is a bimodal age distribution with an incidence of 1.9 cases per 1,000,000 person-years in children ages 0 to 19 and an incidence of 2.1 cases per 1,000,000 person-years in adults aged 40 to 79. The population-adjusted incidence rates suggest that craniopharyngioma has a slightly higher incidence in black persons. There is an even distribution between genders.
Most craniopharyngiomas are located in the parasellar region. Most involve the suprasellar cistern to some degree. Occasionally the tumor can extend into neighboring cranial fossae and rarely is found in ectopic locations. The most common presenting symptoms are related to increased intracranial pressure secondary to obstructive hydrocephalus (eg, headaches, nausea, and vomiting); visual dysfunction from direct compression of the optic chiasm, nerve, or tract; hormonal imbalance from pituitary stalk infiltration; and behavioral/developmental abnormality from hypothalamic injury (occurring primarily in children).
Radiologic and Pathologic Characteristics
There are two major subtypes of craniopharyngioma. The adamantinomatous subtype is more prevalent in children and is thought to arise from neoplastic transformation of epithelial rests within the craniopharyngeal duct. The papillary subtype is almost exclusively found in adults and is thought to derive from metaplastic changes of epithelial cells within the pituitary stalk. Craniopharyngioma are characterized as a World Health Organization grade I neoplasm ( Fig. 1 ).
Most craniopharyngioma range in size from 2 to 4 cm, but can be significantly larger. They often have irregular borders and cystic components (46%–64%). The cystic components tend to be hyperintense on T2-weighted MRI. Enhancement of the cyst wall and heterogeneous enhancement of the solid portions is common. The adamantinomatous variant is frequently calcified. Close review of preoperative imaging is crucial to identify the relationships between the lesion and the chiasm, adjacent vasculature, pituitary stalk, and third ventricle ( Fig. 2 ).
Introduction
Craniopharynigoma are rare, benign tumors of the central nervous system. Thought to arise from remnants of Rathke pouch in the sellar region, they represent less than 1% of all primary central nervous system tumors. Despite their benign histology, these tumors have posed a significant treatment challenge. Their central location in the sellar and suprasellar region and frequent invasion into critical neurovascular structures, such as the pituitary gland, hypothalamus, and optic apparatus, makes gross total resection (GTR) challenging. Although tumors may still recur after GTR the likelihood increases dramatically with subtotal resection. Nevertheless, significant controversy exists regarding the optimal treatment strategy, with some groups pursuing conservative subtotal resection with either upfront or salvage radiotherapy or radiosurgery to lessen the risks of aggressive surgical resection.
As these treatment paradigms have evolved, so too have the surgical techniques and approaches to craniopharyngioma, with the goal of maximizing resection and minimizing collateral damage. Traditional transcranial approaches require some degree of brain retraction and manipulation of cerebrovascular structures that lay between the surgeon and the pathology. The transsphenoidal approach offers a more direct route to the sellar/suprasellar region and if performed with the operating microscope provides only a limited field of view, which often precludes safe and complete resection of these lesions. The use of the transsphenoidal corridor was broadened with the development of expanded approaches, which offered a safe alternative method for reaching suprasellar craniopharyngioma. The incorporation of the endoscope was the next step on the evolutionary ladder. By virtue of an improved field of view and superb illumination, this allowed for further expansion of the endonasal corridor. Finally, the development of a variety of complementary multilayer techniques to repair the skull base minimized the risk of postoperative cerebrospinal fluid (CSF) leak. Several groups have now published their series incorporating these innovations into a fully endoscopic, endonasal, extended transsphenoidal approach for sellar and suprasellar craniopharyngioma.
Epidemiology and Clinical Characteristics
Craniopharyngioma is a histologically benign, but locally aggressive sellar/suprasellar tumor characterized by a propensity to involve surrounding neurovascular structures. The overall incidence rate is between 1.3 and 1.7 cases per 1,000,000 person-years. As is often noted in the literature, there is a bimodal age distribution with an incidence of 1.9 cases per 1,000,000 person-years in children ages 0 to 19 and an incidence of 2.1 cases per 1,000,000 person-years in adults aged 40 to 79. The population-adjusted incidence rates suggest that craniopharyngioma has a slightly higher incidence in black persons. There is an even distribution between genders.
Most craniopharyngiomas are located in the parasellar region. Most involve the suprasellar cistern to some degree. Occasionally the tumor can extend into neighboring cranial fossae and rarely is found in ectopic locations. The most common presenting symptoms are related to increased intracranial pressure secondary to obstructive hydrocephalus (eg, headaches, nausea, and vomiting); visual dysfunction from direct compression of the optic chiasm, nerve, or tract; hormonal imbalance from pituitary stalk infiltration; and behavioral/developmental abnormality from hypothalamic injury (occurring primarily in children).
Radiologic and Pathologic Characteristics
There are two major subtypes of craniopharyngioma. The adamantinomatous subtype is more prevalent in children and is thought to arise from neoplastic transformation of epithelial rests within the craniopharyngeal duct. The papillary subtype is almost exclusively found in adults and is thought to derive from metaplastic changes of epithelial cells within the pituitary stalk. Craniopharyngioma are characterized as a World Health Organization grade I neoplasm ( Fig. 1 ).
Most craniopharyngioma range in size from 2 to 4 cm, but can be significantly larger. They often have irregular borders and cystic components (46%–64%). The cystic components tend to be hyperintense on T2-weighted MRI. Enhancement of the cyst wall and heterogeneous enhancement of the solid portions is common. The adamantinomatous variant is frequently calcified. Close review of preoperative imaging is crucial to identify the relationships between the lesion and the chiasm, adjacent vasculature, pituitary stalk, and third ventricle ( Fig. 2 ).
Treatment goals and planned outcomes
Although histologically benign, these lesions are locally aggressive and mandate intervention for the prevention and/or amelioration of neurologic symptoms. Surgical resection is a critical component of the treatment algorithm for craniopharyngioma. For many years attempted GTR was believed to be paramount to successful management of these lesions, and evidence suggests that recurrence rates are significantly improved when GTR is obtained. With the advent of modern microsurgical techniques, imaging modalities, and improved endocrine management, GTR became feasible with reasonably low morbidity and mortality. Nevertheless, some groups contend that a conservative surgical approach, achieving subtotal resection, followed by radiation therapy should be considered the preferred treatment strategy. The rationale is to avoid potential surgical morbidity that would adversely affect quality of life. This is especially true in children, in whom endocrinologic and hypothalamic injury can be devastating. There is no level 1 or level 2 evidence that supports one management paradigm over the other. Our general philosophy is one that aims to maximize tumor resection while minimizing postoperative complications. In most cases this means an attempt at complete resection with an endoscopic, endonasal approach followed by observation if successful or adjuvant therapy, such as radiation, if residual tumor remains.
The transsphenoidal corridor and endoscopic, endonasal technique can be used to resect sellar and suprasellar craniopharyngioma. A key aspect of this technique is the expansion of the operative field by incorporation of the transtuberculum and transplanum approaches. This approach is adapted for use in tumors extending into the third ventricle, and those extending into the prepontine cistern. The primary limitation of the transsphenoidal approach is its lateral reach, and as a general rule, this approach should not be applied to tumors extending more than a centimeter beyond the lateral limits of the exposure.
Preoperative planning and preparation
Relevant anatomy from preoperative MRI should be reviewed in detail. Particular attention should be paid to the location of the optic nerves/chiasm, internal carotid, anterior cerebral, and middle cerebral arteries, and the pituitary gland/stalk. In addition, a detailed neurologic examination should be performed before any intended surgical intervention. Patients with optic chiasm compression should undergo comprehensive neuro-ophthalmologic evaluation, including formal visual field testing. All patients should undergo neuroendocrine assessment, including measurement of pituitary hormones.